Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $63.08 ($2.5M) on 2018-08-01, disclosed to the SEC on 2018-08-03.
Scheduled sale ($2.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.95 | 13,660 | $860K | 34.4% |
| 2 | $63.08 | 918 | $58K | 2.3% |
| 3 | $63.54 | 5,240 | $333K | 13.3% |
| 4 | $62.71 | 11,600 | $727K | 29.1% |
| 5 | $62.88 | 918 | $58K | 2.3% |
| 6 | $63.19 | 7,300 |
| $461K |
| 18.5% |
| Total | $63.00 avg | 39,636 | $2.5M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |